AMYLOIDOSIS side effect
What is AMYLOIDOSIS ?Drugs associated with AMYLOIDOSIS
ARANESP BRIPLATIN CELEBREX CLOZARIL CORTICOSTEROIDS DIANEAL DIGOXIN DOSTINEX ESTRADERM LENALIDOMIDE MABTHERA PEMETREXED PERMAX REMICADE REVLIMID RITUXAN VELCADE XOPENEXAMYLOIDOSIS : Rituxan Side Effects Report #5680932-7
Consumer or non-health professional from UNITED KINGDOM reported RITUXAN problem on Mar 19, 2008. Male patient, weighting 149.9 lb, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: amyloidosis, hepatitis c, large intestinal haemorrhage, . RITUXAN dosage: 660 MG, QD. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, PREDNISOLONE, CYTARABINE, BLEOMYCIN SULPHATE, METHOTREXATE, ETOPOSIDE, CARBOPLATIN. Patient was hospitalized. Patient died on 07/05/2006.
AMYLOIDOSIS : Revlimid Side Effects Report #5618526-1
REVLIMID problem was reported by a Physician from UNITED STATES on Jan 29, 2008. Female patient, 84 years of age, was diagnosed with amyloidosis and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: amyloidosis, disease progression, renal failure, . REVLIMID dosage: 5 MG, 1 IN 1 D, ORAL. Patient died on 12/26/2007.
AMYLOIDOSIS : Rituxan Side Effects Report #5620612-7
Consumer or non-health professional from UNITED KINGDOM reported RITUXAN problem on Feb 01, 2008. Male patient, weighting 149.9 lb, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: amyloidosis, hepatitis c, large intestinal haemorrhage, . RITUXAN dosage: 660 MG, QD. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, PREDNISOLONE, CYTARABINE, BLEOMYCIN, METHOTREXATE, ETOPOSIDE, CARBOPLATIN. Patient was hospitalized. Patient died on 07/05/2006.
AMYLOIDOSIS : Corticosteroids Side Effects Report #5630115-1
CORTICOSTEROIDS problem was reported by a Consumer or non-health professional from GERMANY on Feb 07, 2008. Female patient, 53 years of age, was diagnosed with heart transplant, bone marrow transplant and was treated with CORTICOSTEROIDS. After drug was administered, patient experienced the following problems/side effects: amyloidosis, cachexia, concomitant disease aggravated, lymphadenectomy, lymphadenopathy, metastatic malignant melanoma, mole excision, . CORTICOSTEROIDS dosage: unknown. During the same period patient was treated with MELPHALAN, CYCLOSPORINE, MYCOPHENOLATE MOFETIL. Patient died.
AMYLOIDOSIS : Revlimid Side Effects Report #5631327-3
Physician from UNITED STATES reported REVLIMID problem on Feb 05, 2008. Female patient, 67 years of age, was diagnosed with amyloidosis and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: amyloidosis, disease progression, . REVLIMID dosage: 15 MG, 1 IN 1 D, ORAL. Patient died on 12/30/2007.
AMYLOIDOSIS : Rituxan Side Effects Report #5646055-8
RITUXAN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 22, 2008. Male patient, weighting 149.9 lb, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: amyloidosis, hepatitis c, large intestinal haemorrhage, . RITUXAN dosage: 660 MG, QD. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, PREDNISOLONE, CYTARABINE, BLEOMYCIN, METHOTREXATE, ETOPOSIDE, CARBOPLATIN. Patient was hospitalized. Patient died on 07/05/2006.
AMYLOIDOSIS : Velcade Side Effects Report #5648116-6
Physician from UNITED KINGDOM reported VELCADE problem on Feb 20, 2008. Male patient was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: amyloidosis, diarrhoea, neutropenic sepsis, oral intake reduced, thrombocytopenia, . VELCADE dosage: unknown. Patient was hospitalized. Patient recovered.
AMYLOIDOSIS : Digoxin Side Effects Report #5662098-2
DIGOXIN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 18, 2008. Male patient was diagnosed with cardiac failure and was treated with DIGOXIN. After drug was administered, patient experienced the following problems/side effects: amyloidosis, atrial fibrillation, bradycardia, cardiac arrest, electromechanical dissociation, hypotension, . DIGOXIN dosage: unknown. During the same period patient was treated with DIURETIC, ACE INHIBITOR, DOPAMINE, METOLAZONE. Patient died.
AMYLOIDOSIS : Mabthera Side Effects Report #5588929-2
Consumer or non-health professional from FINLAND reported MABTHERA problem on Dec 18, 2007. Female patient, 59 years of age, was diagnosed with rheumatoid arthritis and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: amyloidosis, nephrotic syndrome, proteinuria, renal failure, renal failure chronic, . MABTHERA dosage: 1000 MG, UNK. During the same period patient was treated with CALCIUM SUPPLEMENT, VITAMIN D. Patient recovered.
AMYLOIDOSIS : Revlimid Side Effects Report #5592848-5
REVLIMID problem was reported by a Physician from UNITED STATES on Jan 08, 2008. Male patient, 72 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: amyloidosis, cardiac failure congestive, no therapeutic response, renal failure chronic, . REVLIMID dosage: 25 MG, DAILY X21 DAYS, ORAL : 15 MG, DAILY X21 DAYS, ORAL. Patient died on 11/08/2007.
AMYLOIDOSIS : Velcade Side Effects Report #5608196-0
Consumer or non-health professional from UNITED KINGDOM reported VELCADE problem on Jan 14, 2008. Male patient was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: amyloidosis, anorexia, diarrhoea, neutropenia, neutropenic sepsis, . VELCADE dosage: unknown. Patient was hospitalized. Patient recovered.
AMYLOIDOSIS : Revlimid Side Effects Report #5643371-0
REVLIMID problem was reported by a Physician from UNITED STATES on Nov 19, 2007. Female patient, 58 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: amyloidosis, asthenia, bedridden, decreased appetite, diarrhoea, disease progression, lethargy, malaise, . REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL. Patient was hospitalized. Patient died.
AMYLOIDOSIS : Remicade Side Effects Report #5534745-7
Health Professional from UNITED KINGDOM reported REMICADE problem on Nov 27, 2007. Male patient, weighting 149.9 lb, was diagnosed with rheumatoid arthritis and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: amyloidosis, cardiac failure, . REMICADE dosage: unknown. During the same period patient was treated with PREDNISOLONE, ACTONEL, LIPITOR, RAMIPRIL, DIAGLYK. Patient was hospitalized. Patient died on 07/17/2007.
AMYLOIDOSIS : Clozaril Side Effects Report #5536924-1
CLOZARIL problem was reported by a Physician from CANADA on Dec 03, 2007. Male patient, 50 years of age, was diagnosed with schizophrenia and was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: amyloidosis, antisocial behaviour, anxiety, ascites, cachexia, computerised tomogram abnormal, confusional state, congestive cardiomyopathy, discomfort, . CLOZARIL dosage: 500 MG, QD. During the same period patient was treated with OLANZAPINE, ATORVASTATIN, FERROUS GLUCONATE, HEPARIN, OXYGEN. Patient was hospitalized. Patient died on 11/20/2007.
AMYLOIDOSIS : Revlimid Side Effects Report #5549231-8
Physician from UNITED STATES reported REVLIMID problem on Dec 04, 2007. Male patient, 62 years of age, weighting 220.0 lb, was diagnosed with amyloidosis and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: amyloidosis, disease progression, staphylococcal sepsis, . REVLIMID dosage: 25 MG, QD X21 DAYS EVERY 28 DAYS, ORAL. During the same period patient was treated with DEXAMETHASONE, MELPHALAN, PREDNISONE, BUMEX, FAMVIR, OXYCODONE, PLAVIX, ASPIRIN. Patient died on 10/20/2007.
AMYLOIDOSIS : Rituxan Side Effects Report #5577190-0
RITUXAN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Dec 17, 2007. Male patient, 45 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: amyloidosis, hepatitis c, large intestinal haemorrhage, . RITUXAN dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, PREDNISOLONE, CYTARABINE, BLEOMYCIN, METHOTREXATE, ETOPOSIDE, CARBOPLATIN. Patient was hospitalized. Patient died on 07/01/2006.
AMYLOIDOSIS : Revlimid Side Effects Report #5577787-8
Physician from UNITED STATES reported REVLIMID problem on Dec 18, 2007. Male patient, 73 years of age, was diagnosed with amyloidosis and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: amyloidosis, cachexia, disease progression, restrictive cardiomyopathy, . REVLIMID dosage: 25 MG, QD, ORAL. Patient died on 10/01/2007.
AMYLOIDOSIS : Xopenex Side Effects Report #5577831-8
XOPENEX problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 17, 2007. Female patient, 72 years of age, was diagnosed with chronic obstructive pulmonary disease, emphysema and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: amyloidosis, cardiac failure, condition aggravated, malaise, nasopharyngitis, palpitations, pulmonary oedema, . XOPENEX dosage: 1.25 MG/3ML; 1X; INHALATION; 0.63 MG/ 3ML; TID; INHALATION. During the same period patient was treated with ALBUTEROL. Patient was hospitalized. Patient recovered.
AMYLOIDOSIS : Revlimid Side Effects Report #5577875-6
Physician from UNITED STATES reported REVLIMID problem on Dec 18, 2007. Female patient, 59 years of age, was diagnosed with amyloidosis, multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: amyloidosis, disease progression, multiple myeloma, . REVLIMID dosage: 15 MG, 1 IN 1 D, ORAL. Patient died on 10/31/2007.
AMYLOIDOSIS : Dianeal Side Effects Report #5507906-0
DIANEAL problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 02, 2007. Female patient, 63 years of age, weighting 180.8 lb, was diagnosed with peritoneal dialysis and was treated with DIANEAL. After drug was administered, patient experienced the following problems/side effects: amyloidosis, diaphragmatic rupture, hypertension, pleural effusion, . DIANEAL dosage: unknown. Patient was hospitalized. Patient recovered.
AMYLOIDOSIS : Pemetrexed Side Effects Report #5507916-3
Physician from JAPAN reported PEMETREXED problem on Oct 23, 2007. Female patient, 72 years of age, weighting 85.98 lb, was diagnosed with pleural mesothelioma malignant, iron deficiency anaemia, cholelithiasis and was treated with PEMETREXED. After drug was administered, patient experienced the following problems/side effects: amyloidosis, blood albumin decreased, decreased appetite, diarrhoea, febrile neutropenia, gastric ulcer, haematocrit decreased, haemoglobin decreased, oedema, . PEMETREXED dosage: unknown. During the same period patient was treated with CISPLATIN, PANVITAN, METHYCOBAL, FERROMIA, URSO. Patient was hospitalized. Patient recovered.
AMYLOIDOSIS : Velcade Side Effects Report #5509025-6
VELCADE problem was reported by a Physician from AUSTRALIA on Oct 24, 2007. Female patient, 78 years of age, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: amyloidosis, cerebral haemorrhage, disease progression, febrile infection, hyperviscosity syndrome, infusion site infection, thrombocytopenia, . VELCADE dosage: 2.30 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, ROMIDEPSIN. Patient was hospitalized. Patient died on 04/17/2007.
AMYLOIDOSIS : Briplatin Side Effects Report #5510153-X
Consumer or non-health professional from UNITED STATES reported BRIPLATIN problem on Nov 06, 2007. Female patient, 72 years of age, weighting 85.98 lb, was diagnosed with pleural mesothelioma malignant and was treated with BRIPLATIN. After drug was administered, patient experienced the following problems/side effects: amyloidosis, anorexia, aspartate aminotransferase increased, blood albumin decreased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, diarrhoea, febrile neutropenia, gastric ulcer, . BRIPLATIN dosage: unknown. During the same period patient was treated with ALIMTA, RANDA, PANVITAN, METHYCOBAL, FERROMIA, URSO, FLOPROPIONE, TANNALBIN. Patient was hospitalized. Patient recovered.
AMYLOIDOSIS : Permax Side Effects Report #5526190-5
PERMAX problem was reported by a Physician from GERMANY on Nov 02, 2007. Male patient was diagnosed with parkinson's disease and was treated with PERMAX. After drug was administered, patient experienced the following problems/side effects: amyloidosis, anaemia, atelectasis, depression, gamma-glutamyltransferase increased, pericarditis constrictive, pleural effusion, pleural fibrosis, pneumonia, . PERMAX dosage: 1 MG;QID;PO. During the same period patient was treated with LEVODOPA, CLOZAPINE, DIOVAN HCT, CARBIDOPA, COMTESS, FUROSEMIDE. Patient was hospitalized. Patient recovered.
AMYLOIDOSIS : Estraderm Side Effects Report #5528970-9
Physician from UNITED STATES reported ESTRADERM problem on June 01, 2007. Female patient, 60 years of age, weighting 185.0 lb, was diagnosed with menopause and was treated with ESTRADERM. After drug was administered, patient experienced the following problems/side effects: amyloidosis, breast cancer in situ, breast hyperplasia, breast microcalcification, fibrocystic breast disease, hypertension, mastectomy, oedema peripheral, osteoarthritis, . ESTRADERM dosage: unknown. During the same period patient was treated with PREMPRO, PROVERA, CYCRIN, MEDROXYPROGESTERONE ACETATE, ELAVIL, AMITRIPTYLINE, ASACOL, HYOSCYAMINE. Patient recovered.
AMYLOIDOSIS : Celebrex Side Effects Report #5530956-5
CELEBREX problem was reported by a Physician from UNITED STATES on Nov 20, 2007. Female patient, 84 years of age, was diagnosed with osteoarthritis, blood pressure and was treated with CELEBREX. After drug was administered, patient experienced the following problems/side effects: amyloidosis, face oedema, multiple myeloma, rash, . CELEBREX dosage: DAILY DOSE:200MG. During the same period patient was treated with NORVASC. Patient recovered.
AMYLOIDOSIS : Lenalidomide Side Effects Report #5531837-3
Pharmacist from UNITED STATES reported LENALIDOMIDE problem on Nov 27, 2007. Male patient, 57 years of age, weighting 153.0 lb, was diagnosed with multiple myeloma and was treated with LENALIDOMIDE. After drug was administered, patient experienced the following problems/side effects: amyloidosis, cardiac enzymes increased, cardiac failure congestive, myocarditis, pulmonary oedema, . LENALIDOMIDE dosage: 25MG EVERY DAY PO. Patient was hospitalized. Patient recovered.
AMYLOIDOSIS : Dostinex Side Effects Report #5473612-4
DOSTINEX problem was reported by a Physician from UNITED STATES on July 06, 2006. Male patient, weighting 205.0 lb, was diagnosed with prolactinoma and was treated with DOSTINEX. After drug was administered, patient experienced the following problems/side effects: amyloidosis, blood albumin abnormal, body height decreased, proteinuria, . DOSTINEX dosage: unknown. During the same period patient was treated with COZAAR, FIORICET, VITAMIN CAP, ASCORBIC ACID, SAW PALMETTO, PEPCID AC. Patient recovered.
AMYLOIDOSIS : Briplatin Side Effects Report #5480660-7
Health Professional from JAPAN reported BRIPLATIN problem on Sept 28, 2007. Female patient, 72 years of age, weighting 85.98 lb, was diagnosed with pleural mesothelioma malignant and was treated with BRIPLATIN. After drug was administered, patient experienced the following problems/side effects: amyloidosis, anorexia, aspartate aminotransferase increased, blood albumin decreased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, diarrhoea, febrile neutropenia, gastric ulcer, . BRIPLATIN dosage: unknown. During the same period patient was treated with ALIMTA, PANVITAN, METHYCOBAL, FERROMIA, URSO, FLOPROPIONE, TANNALBIN, ALFAROL. Patient was hospitalized. Patient recovered.
AMYLOIDOSIS : Dianeal Side Effects Report #5489740-3
DIANEAL problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 11, 2007. Female patient, 63 years of age, weighting 180.8 lb, was diagnosed with peritoneal dialysis and was treated with DIANEAL. After drug was administered, patient experienced the following problems/side effects: amyloidosis, diaphragmatic rupture, hypertension, pleural effusion, . DIANEAL dosage: unknown. Patient was hospitalized. Patient recovered.
AMYLOIDOSIS : Briplatin Side Effects Report #5500765-1
Health Professional from JAPAN reported BRIPLATIN problem on Oct 24, 2007. Female patient, 72 years of age, weighting 85.98 lb, was diagnosed with pleural mesothelioma malignant and was treated with BRIPLATIN. After drug was administered, patient experienced the following problems/side effects: amyloidosis, anorexia, aspartate aminotransferase increased, blood albumin decreased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, diarrhoea, febrile neutropenia, gastric ulcer, . BRIPLATIN dosage: unknown. During the same period patient was treated with ALIMTA, RANDA, PANVITAN, METHYCOBAL, FERROMIA, URSO, FLOPROPIONE, TANNALBIN. Patient was hospitalized. Patient recovered.
AMYLOIDOSIS : Revlimid Side Effects Report #5445652-2
REVLIMID problem was reported by a Physician from UNITED STATES on Aug 28, 2007. Male patient, 79 years of age, was diagnosed with amyloidosis, multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: amyloidosis, cardiac failure, disease progression, dizziness, gait disturbance, monoclonal immunoglobulin present, multiple myeloma, urine analysis abnormal, . REVLIMID dosage: 5 MG, 1 IN 1 D, ORAL; 15 MG, 1 IN 1 D, ORAL. During the same period patient was treated with LASIX. Patient died on 03/24/2007.
AMYLOIDOSIS : Briplatin Side Effects Report #5455347-7
Health Professional from JAPAN reported BRIPLATIN problem on Sept 13, 2007. Female patient, 72 years of age, was diagnosed with pleural mesothelioma malignant and was treated with BRIPLATIN. After drug was administered, patient experienced the following problems/side effects: amyloidosis, aspartate aminotransferase increased, blood albumin decreased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, decreased appetite, diarrhoea, febrile neutropenia, gastric ulcer, . BRIPLATIN dosage: unknown. During the same period patient was treated with ALIMTA, PANVITAN, MECOBALAMIN, FERROMIA, URSO, FLOPROPIONE, TANNALBIN, ALFAROL. Patient was hospitalized. Patient recovered.
AMYLOIDOSIS : Briplatin Side Effects Report #5458658-4
BRIPLATIN problem was reported by a Health Professional from JAPAN on Sept 13, 2007. Female patient, 72 years of age, was diagnosed with pleural mesothelioma malignant and was treated with BRIPLATIN. After drug was administered, patient experienced the following problems/side effects: amyloidosis, aspartate aminotransferase increased, blood albumin decreased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, decreased appetite, diarrhoea, febrile neutropenia, gastric ulcer, . BRIPLATIN dosage: unknown. During the same period patient was treated with ALIMTA, PANVITAN, MECOBALAMIN, FERROMIA, URSO, FLOPROPIONE, TANNALBIN, ALFAROL. Patient was hospitalized. Patient recovered.
AMYLOIDOSIS : Pemetrexed Side Effects Report #5469876-3
Physician from JAPAN reported PEMETREXED problem on Sept 13, 2007. Female patient, 72 years of age, weighting 85.98 lb, was diagnosed with pleural mesothelioma malignant, iron deficiency anaemia, cholelithiasis, osteoporosis and was treated with PEMETREXED. After drug was administered, patient experienced the following problems/side effects: amyloidosis, blood albumin decreased, decreased appetite, diarrhoea, febrile neutropenia, gastric ulcer, haematocrit decreased, haemoglobin decreased, oedema, . PEMETREXED dosage: unknown. During the same period patient was treated with PANVITAN, METHYCOBAL, FERROMIA, URSO, COSPANON, ALFAROL. Patient was hospitalized. Patient recovered.
AMYLOIDOSIS : Aranesp Side Effects Report #5381754-7
ARANESP problem was reported by a Health Professional from AUSTRALIA on June 26, 2007. Male patient, weighting 154.3 lb, was diagnosed with dialysis and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: amyloidosis, cardiac arrest, dehydration, delirium, diarrhoea, dyspnoea, fatigue, hypercalcaemia, hypocalcaemia, . ARANESP dosage: unknown. During the same period patient was treated with THALIDOMIDE, ATORVASTATIN, DEXAMETHASONE, METOPROLOL SUCCINATE, OMEPRAZOLE, CALTRATE, PARACETAMOL. Patient was hospitalized. Patient died on 09/13/2005.
AMYLOIDOSIS : Revlimid Side Effects Report #5402165-1
Physician from UNITED STATES reported REVLIMID problem on July 24, 2007. Male patient, 60 years of age, was diagnosed with amyloidosis and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: amyloidosis, confusional state, disease progression, suicidal ideation, . REVLIMID dosage: 15 MG, DAILY X 21 DAYS, ORAL; 5 MG, X 21 DAYS, ORAL. Patient was hospitalized. Patient died on 05/01/2007.
AMYLOIDOSIS : Aranesp Side Effects Report #5381754-7
ARANESP problem was reported by a Health Professional from AUSTRALIA on June 26, 2007. Male patient, weighting 154.3 lb, was diagnosed with dialysis and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: amyloidosis, cardiac arrest, dehydration, delirium, diarrhoea, dyspnoea, fatigue, hypercalcaemia, hypocalcaemia, . ARANESP dosage: unknown. During the same period patient was treated with THALIDOMIDE, ATORVASTATIN, DEXAMETHASONE, METOPROLOL SUCCINATE, OMEPRAZOLE, CALTRATE, PARACETAMOL. Patient was hospitalized. Patient died on 09/13/2005.
AMYLOIDOSIS : Revlimid Side Effects Report #5402165-1
Physician from UNITED STATES reported REVLIMID problem on July 24, 2007. Male patient, 60 years of age, was diagnosed with amyloidosis and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: amyloidosis, confusional state, disease progression, suicidal ideation, . REVLIMID dosage: 15 MG, DAILY X 21 DAYS, ORAL; 5 MG, X 21 DAYS, ORAL. Patient was hospitalized. Patient died on 05/01/2007.